Newsroom | 5106 results

Sorted by: Latest

Diabetes
-

New EndoTool IV Data Presented at AACE Show Virtual Elimination of Severe Hypoglycemia Across 19 Hospitals

PALO ALTO, Calif. & LAS VEGAS--(BUSINESS WIRE)--Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced data presented at the American Association of Clinical Endocrinology (AACE) Annual Meeting. The evidence, reflecting outcomes from a three-year retrospective analysis spanning from January 2023 through December 2025, demonstrated that EndoT...
-

Outcome Capital Further Bolsters Its Platform with the Addition of Jaison Ellis

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Jaison Ellis has joined the firm as a Managing Director, based in Charlotte, NC. The firm continues to expand its life sciences and healthcare practices through its unique, market-aligned, strategy-driven platform, delivering mergers and acquisitions, partnerships, and strategic advisory services. “I’m delighted to join such a distinguished...
-

Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced it has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. Welldoc will participate in both the Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks, bringing its AI-driven clinical platform to Medicare beneficiaries living with diabetes, obesity, hypertension, a...
-

WHS Recognizes Eluciderm, Inc. with Industrial R&D Award for Research on ELU42 Mechanism of Action

SAN DIEGO--(BUSINESS WIRE)--Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics to promote healing and regenerative repair of injured tissue, announced today that it received the Wound Healing Society’s Industrial Research & Development Poster Presentation Award at the 2026 Symposium on Advanced Wound Care (SAWC 2026). The award was presented to Eluciderm’s Vice President of Molecular Biology, Dr. Sarika Saraswati, PhD, on April 10th for her work...
-

City of Hope Scientists to Share New Findings on Cancer Risk, Immune Resistance and AI‑Driven Discovery at AACR 2026

LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present new data at the AACR Annual Meeting 2026, sharing insights into cancer risk, treatment resistance and emerging therapeutic strategies across solid and blood cancers. From April 17–22, expertise from City of Hope...
-

AdaptHealth Corp. Announces First Quarter 2026 Earnings Release Date and Conference Call

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2026 financial results before the opening of the financial markets on Tuesday, May 5, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and in...
-

4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...
-

ELRIG Announces Inaugural US Drug Discovery Conference

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....
-

WHOOP Selected for Inclusion in CMS’s ACCESS Program to Bring Technology-Enabled Care to Medicare Beneficiaries

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced that its affiliated health care provider, WHOOP Physician Services, PC, was selected into the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s ACCESS program, a new initiative designed to expand access to high-quality, technology-enabled care for Medicare beneficiaries managing chronic conditions. Through this program, eligible Medicare beneficiaries will be able to receive WHOOP and its data-dr...
-

Nearly Half of Local Adults May Have Prediabetes and Not Know It

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--El Camino Healthcare District launches free self-screening and dietitian program to help adults detect and reduce prediabetes risk....